This suggests a ubiquitous role for LDLR in high grade glioma metabolism, which could be exploited in developing novel future therapeutic strategies for both adult and paediatric anaplastic astrocytoma and glioblastoma cases. The gene discussed is LDLR; the disease is central nervous system cancer.